We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Supplemental profits

15 July 2010 By Christopher Swann

The private equity firm’s $3.8 bln purchase of supplementsmaker NBTY is its biggest in ages. But it’s not immediately clear what extra juice Carlyle can add to the business to generate outsized returns. Without that, it could just be a deal for a deal’s sake.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)